Invention Grant
- Patent Title: Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies
-
Application No.: US16373397Application Date: 2019-04-02
-
Publication No.: US10647706B2Publication Date: 2020-05-12
- Inventor: Branislav Musicki , Yushma Bhurruth-Alcor
- Applicant: GALDERMA RESEARCH & DEVELOPMENT
- Applicant Address: FR Biot
- Assignee: GALDERMA RESEARCH & DEVELOPMENT
- Current Assignee: GALDERMA RESEARCH & DEVELOPMENT
- Current Assignee Address: FR Biot
- Agency: Foley & Lardner LLP
- Agent Sunit Talapatra
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@7e36d1a0
- Main IPC: C07D409/06
- IPC: C07D409/06 ; C07D213/75 ; C07D407/12 ; C07C381/10 ; C07D213/38 ; C07D307/52 ; C07D405/12
Abstract:
Novel chemokine CXCR1 and CXCR2 receptor antagonist compounds of general formula (I) are described. Also described, are pharmaceutical compositions including the compounds, and use of the compounds and the compositions for the treatment of chemokine-mediated pathologies, more specifically in the field of dermatology.
Public/Granted literature
Information query
